AU2572797A - Adam proteins and uses thereof - Google Patents

Adam proteins and uses thereof

Info

Publication number
AU2572797A
AU2572797A AU25727/97A AU2572797A AU2572797A AU 2572797 A AU2572797 A AU 2572797A AU 25727/97 A AU25727/97 A AU 25727/97A AU 2572797 A AU2572797 A AU 2572797A AU 2572797 A AU2572797 A AU 2572797A
Authority
AU
Australia
Prior art keywords
adam proteins
adam
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25727/97A
Inventor
Peter Ian Croucher
Norman Mckie
Robert Graham Goodwin Russell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sheffield
Original Assignee
University of Sheffield
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sheffield filed Critical University of Sheffield
Publication of AU2572797A publication Critical patent/AU2572797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU25727/97A 1996-04-19 1997-04-16 Adam proteins and uses thereof Abandoned AU2572797A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9608130.2A GB9608130D0 (en) 1996-04-19 1996-04-19 Adam proteins and uses thereof
GB9608130 1996-04-19
PCT/GB1997/001067 WO1997040072A2 (en) 1996-04-19 1997-04-16 Adam proteins and uses thereof

Publications (1)

Publication Number Publication Date
AU2572797A true AU2572797A (en) 1997-11-12

Family

ID=10792345

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25727/97A Abandoned AU2572797A (en) 1996-04-19 1997-04-16 Adam proteins and uses thereof

Country Status (4)

Country Link
EP (1) EP0894132A2 (en)
AU (1) AU2572797A (en)
GB (1) GB9608130D0 (en)
WO (1) WO1997040072A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7333296A (en) 1996-02-23 1997-09-10 Mochida Pharmaceutical Co., Ltd. Meltrins
US6265199B1 (en) 1998-07-10 2001-07-24 Zymogenetics, Inc. Disintegrin homologs
AU4983399A (en) * 1998-07-10 2000-02-01 Zymogenetics Inc. Disintegrin homologs
JP2003508028A (en) 1999-07-28 2003-03-04 ジェネンテック・インコーポレーテッド Compositions and methods for treating tumors
JP2003525029A (en) * 1999-08-03 2003-08-26 ザイモジェネティクス，インコーポレイティド Mammalian adhesive protease peptide
DE10337368A1 (en) * 2003-08-08 2005-03-03 Technische Universität Dresden Diagnosis of pancreatic cancer by detecting expression of the a disintegrin and metalloprotease domain 9 (ADAM9) protein using specific antibodies, also therapeutic use of these antibodies and of ADAM9-specific nucleic acids
CN1930461A (en) 2004-01-09 2007-03-14 儿童医疗中心有限公司 Methods for diagnosis and pronosis of cancers of epithelial origin
GB0408684D0 (en) * 2004-04-19 2004-05-19 Guy S And St Thomas Hospital N Diagnostic method
WO2006014903A2 (en) * 2004-07-27 2006-02-09 Five Prime Therapeutics, Inc. Compositions and methods of use for adam12 antagonists in treating disease
US7674597B2 (en) 2004-08-02 2010-03-09 Elan Pharmaceuticals, Inc. Signaling intermediates in an in vitro model of Alzheimer's disease
US8012947B2 (en) 2007-03-15 2011-09-06 Hospital For Special Surgery Methods and compositions for promoting wound healing
CA3056116A1 (en) 2007-06-22 2008-12-31 Randolph Watnick Methods and uses thereof of prosaposin
GB2453589A (en) 2007-10-12 2009-04-15 King S College London Protease inhibition
AU2009335000B2 (en) 2008-12-30 2014-11-13 Children's Medical Center Corporation Method of predicting acute appendicitis
CA2676946A1 (en) 2009-08-28 2011-02-28 Lucie Peduto Adam12 inhibitors and their use against inflammation-induced fibrosis
WO2011069093A1 (en) 2009-12-04 2011-06-09 Boston Biomedical Research Institute, Inc. Detecting and counting tissue-specific stem cells and uses thereof
CA2822026C (en) 2009-12-17 2018-06-12 Children's Medical Center Corporation Saposin-a derived peptides and uses thereof
WO2013096868A2 (en) 2011-12-22 2013-06-27 Children's Medical Center Corporation Saposin-a derived peptides and uses thereof
WO2014078713A1 (en) * 2012-11-15 2014-05-22 Feldman Brian Jay Modulation of muscle and adipocyte distribution and fate
WO2020006273A1 (en) * 2018-06-27 2020-01-02 Juvena Therapeutics, Inc. Heparin-associated polypeptides and uses thereof
CN114569709B (en) * 2022-05-05 2022-07-12 苏州慧疗生物医药科技有限公司 Preparation method and application of melanoma autologous tumor vaccine with high ADAM-28 expression

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693496A (en) * 1994-06-20 1997-12-02 Merck & Co., Inc. DNA encoding the mouse and human PH30 beta chain protein

Also Published As

Publication number Publication date
WO1997040072A3 (en) 1998-03-26
EP0894132A2 (en) 1999-02-03
WO1997040072A2 (en) 1997-10-30
GB9608130D0 (en) 1996-06-26

Similar Documents

Publication Publication Date Title
AU5752398A (en) Novel ketobenzamides and their use
AU4922497A (en) Interleukin-18-receptor proteins
AU6241698A (en) Tace-like and matrilysin-like polypeptides
EP1021185A4 (en) Didhydropyrimidines and uses thereof
AU1088399A (en) F-box proteins and genes
AU5721798A (en) Human mage-like protein
AU2572797A (en) Adam proteins and uses thereof
AU9781998A (en) Huchordin and uses thereof
AU6721696A (en) Cd44-like protein
AU5091199A (en) Prion protein and uses thereof
AU3227197A (en) Lactoferrin variants and uses thereof
AU5340399A (en) Proteases and associated proteins
GB9705903D0 (en) VP22 Proteins and uses thereof
AU3902297A (en) Two human nsp-like proteins
AU7419396A (en) Clothespin and clothes-equipment
AU2396600A (en) Secreted proteins and uses thereof
AU4480697A (en) Human nm23-like protein
AU3451397A (en) Modified protein g and fragments thereof
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
GB9423372D0 (en) Proteins and their uses
AU6000698A (en) Proteins
AU4906597A (en) Human guanylate-binding proteins
AU1326200A (en) Ovary-specific genes and proteins
AU5188296A (en) Carbopeptoids and carbonucleotoids
AU4744997A (en) Novel human phospholemman-like protein